Houston-based University of Texas MD Anderson Cancer Center is the first International Atomic Energy Agency Collaborating Centre in the United States focused on healthcare.

Alexandra Miller, MD, PhD, a neurologist and neuro-oncologist who specializes in brain tumors, was named chief of the neuro-oncology program and co-director of the Brain and Spine Tumor Center at New York City-based NYU Langone's Perlmutter Cancer Center.

Calling the lowest-risk prostate cancers something else may encourage some patients to follow physicians' treatment recommendations of active surveillance and avoid pursuing more aggressive options, according to a growing number of physicians advocating for a change in nomenclature, The Wall Street Journal reported Jan. 24.

Researchers have identified 921 chemicals thought to increase the risk of breast cancer and say none should be considered "low hazard" until further investigation is done.

Los Angeles-based Cedars-Sinai is using artificial intelligence to improve prediction of and treatment for pancreatic cancer, according to a Jan. 22 news release. 

In an interactive session hosted by GRAIL at Becker's 11th Annual CEO + CFO Roundtable, Roni Christopher, DHSc, senior director of care delivery at GRAIL, and Adam Whitten, vice president of operations at Mercy (St. Louis), discussed how multi-cancer early detection testing can support health systems and patient outcomes.

Biotech company Orbis Health Solutions was approved to begin a phase 3 clinical trial of its melanoma vaccine, ABC News reported Jan. 20.

This is the first year since the COVID-19 pandemic began that hospitals must independently decide if and how to implement masking, and cancer centers across the country are taking different approaches.

Los Angeles-based UCLA Health appointed Mediget Teshome, MD, chief of breast surgery and director of breast health.

The FDA recently approved the nation's first artificial intelligence-powered medical device that detects skin cancer. 

Drugmakers have their sights set on a class of cancer drugs known as antibody drug conjugates, or ADCs, to drive growth, CNBC reported Jan. 14. 

The expected increase in new cancer diagnoses this year is record-setting, even as overall cancer mortality is expected to continue its decline, the American Cancer Society said in its latest report.

Substance use disorders are highly variable among cancer patient populations, and new research points to five cancers with the highest prevalence of SUDs, according to a study published Jan. 11 in JAMA. 

A combination of artificial intelligence and image screening software used by a blogger allegedly found evidence of data manipulation across a range of research papers published by four experts at the Dana-Farber Cancer Institute in Boston dating back to 1997.

West Orange, N.J.-based RWJBarnabas Health has three new cancer centers under construction, including New Jersey's first freestanding cancer center.

Cancer diagnosis rates among people under 50 are on the rise. In the U.S, the rate among this group jumped nearly 13% from 2000 — when it was 95.6 cases per 100,000 people — to 107.8 by 2019. Physicians and scientists are baffled, scrambling to determine what's beneath the surge and how to identify people at high risk, The Wall Street Journal reported Jan. 11.

An American Cancer Society study found states with expanded Medicaid status had more insurance coverage for newly diagnosed cancer patients and fewer uninsured patients.

City of Hope and Children's Oncology Group researchers conducted the largest clinical trial to date to investigate the prevention of childhood cancer survivors from developing heart failure.

Four groups are asking policymakers to address the "urgent threat facing cancer treatment access" by changing Medicare payments.

Jacksonville, Fla.-based Nemours Children's Health researchers found the Zika virus could be used to shrink neuroblastoma tumors.